Article

Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory

2023-09-29

Abstract excerpt

Current immunotherapies have proven effective in strengthening anti-tumor immune responses but constant opposing signals from tumor cells and surrounding microenvironment eventually lead to immune escape. We hypothesize that in situ release of antigens and regulation of both the innate and adaptive arms of the immune system will provide a robust and long-term anti-tumor effect by creating immunological memory agai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7fccbf43-e04f-5ee2-ab71-2f63cd5ad519
DOI: 10.1101/2023.09.27.559828

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memoryDOI 10.1101/2023.09.27.559828Read

Suppression of multiple mouse models of refractory malignancies by reprogramming IL-18 ligand-receptor interactionSemantic proximity Read

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlightsSemantic proximity Read

The oncolytic virus ΔPK has multimodal anti-tumor activity.Semantic proximity Read

Non-lytic replicating viral delivery of an IL15 superagonist enhances antitumor immunity and extends survival in glioblastomaSemantic proximity Read

A novel immunogene therapy to cancer with high tumor selectivity and safetySemantic proximity Read

IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal AdenocarcinomaSemantic proximity Read

Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacySemantic proximity Read

Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic VirotherapySemantic proximity Read

A Replication‐Defective Myxoma Virus Inducing Pro‐Inflammatory Responses as Monotherapy and an Adjuvant to Chemo‐ and DC Immuno‐Therapy for Ovarian CancerSemantic proximity Read

ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cellsSemantic proximity Read

Clinical outcomes of chimeric antigen receptor T cell therapy in 21 patients with Relapse/Refractory Ileocecal Region B cell lymphomaSemantic proximity Read

Tumor cell intrinsic RIG-I activation co-opts the host microenvironment to drive immune mediated tumor rejectionSemantic proximity Read